Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Loda

Showing results (281-290 of 409) with videos related to

Pageof 41
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell cycle inhibitorRobert I Haddad, Lisa J Weinstein, Tad J Wieczorek, et al.
Molecular Cancer Research : MCR|November 10, 2020
Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and SerumKathryn L Penney, Svitlana Tyekucheva, Jacob Rosenthal, et al.
Cancer & Metabolism|December 17, 2016
The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control studyRachel S Kelly, Jennifer A Sinnott, Jennifer R Rider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survivalPaul L Nguyen, Jing Ma, Jorge E Chavarro, et al.
Science Translational Medicine|May 3, 2023
Therapeutic blocking of VEGF binding to neuropilin-2 diminishes PD-L1 expression to activate antitumor immunity in prostate cancerMengdie Wang, Christi A Wisniewski, Choua Xiong, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 16, 2018
A Prospective Study of Aspirin Use and Prostate Cancer Risk by <i>TMPRSS2:ERG</i> StatusKonrad H Stopsack, Amparo G Gonzalez-Feliciano, Samuel F Peisch, et al.
Molecular Cancer Research : MCR|August 5, 2025
Tumor Cholesterol Synthesis, Statin Use, and Lethal Prostate CancerSinead Flanagan, Rosina T Lis, Ying Huang, et al.
Cancer Biomarkers : Section a of Disease Markers|December 24, 2016
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutesAnna Caliò, Emilio Bria, Sara Pilotto, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Canonical AREs are tumor suppressive regulatory elements in the prostateMichael A Augello, Xuanrong Chen, Deli Liu, et al.
Molecular Cancer Research : MCR|March 4, 2006
Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancerSimona Nanni, Carmen Priolo, Annalisa Grasselli, et al.
Pageof 41

Showing results (281-290 of 409) with videos related to

Sort By:
Pageof 41
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell cycle inhibitorRobert I Haddad, Lisa J Weinstein, Tad J Wieczorek, et al.
Molecular Cancer Research : MCR|November 10, 2020
Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and SerumKathryn L Penney, Svitlana Tyekucheva, Jacob Rosenthal, et al.
Cancer & Metabolism|December 17, 2016
The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control studyRachel S Kelly, Jennifer A Sinnott, Jennifer R Rider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survivalPaul L Nguyen, Jing Ma, Jorge E Chavarro, et al.
Science Translational Medicine|May 3, 2023
Therapeutic blocking of VEGF binding to neuropilin-2 diminishes PD-L1 expression to activate antitumor immunity in prostate cancerMengdie Wang, Christi A Wisniewski, Choua Xiong, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 16, 2018
A Prospective Study of Aspirin Use and Prostate Cancer Risk by <i>TMPRSS2:ERG</i> StatusKonrad H Stopsack, Amparo G Gonzalez-Feliciano, Samuel F Peisch, et al.
Molecular Cancer Research : MCR|August 5, 2025
Tumor Cholesterol Synthesis, Statin Use, and Lethal Prostate CancerSinead Flanagan, Rosina T Lis, Ying Huang, et al.
Cancer Biomarkers : Section a of Disease Markers|December 24, 2016
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutesAnna Caliò, Emilio Bria, Sara Pilotto, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Canonical AREs are tumor suppressive regulatory elements in the prostateMichael A Augello, Xuanrong Chen, Deli Liu, et al.
Molecular Cancer Research : MCR|March 4, 2006
Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancerSimona Nanni, Carmen Priolo, Annalisa Grasselli, et al.
Pageof 41